Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • ASCI Milestone Awards
    • Video Abstracts
    • Conversations with Giants in Medicine
  • Reviews
    • View all reviews ...
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • ASCI Milestone Awards
  • Video Abstracts
  • Conversations with Giants in Medicine
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Epimorphin–/– mice have increased intestinal growth, decreased susceptibility to dextran sodium sulfate colitis, and impaired spermatogenesis
Yuan Wang, Lihua Wang, Hristo Iordanov, Elzbieta A. Swietlicki, Qun Zheng, Shujun Jiang, Yuzhu Tang, Marc S. Levin, Deborah C. Rubin
Yuan Wang, Lihua Wang, Hristo Iordanov, Elzbieta A. Swietlicki, Qun Zheng, Shujun Jiang, Yuzhu Tang, Marc S. Levin, Deborah C. Rubin
View: Text | PDF
Research Article Development

Epimorphin–/– mice have increased intestinal growth, decreased susceptibility to dextran sodium sulfate colitis, and impaired spermatogenesis

  • Text
  • PDF
Abstract

Dynamic and reciprocal epithelial-mesenchymal interactions are critical for the normal morphogenesis and maintenance of epithelia. Epimorphin has been identified as a unique molecule expressed by mesenchymal cells and myofibroblasts and has putative morphogenetic effects in multiple epithelial tissues, including intestine, skin, mammary gland, lung, gallbladder, and liver. To define the in vivo role of epimorphin, we created epimorphin-null mice by targeted inactivation of the epimorphin gene. Male epimorphin–/– mice are sterile due to abnormal testicular development and impaired spermatogenesis. Intestinal growth is increased in epimorphin–/– mice due to augmented crypt cell proliferation and crypt fission during the neonatal (suckling) period, mediated at least in part by changes in bone morphogenetic protein (Bmp) and Wnt/β-catenin signaling pathways. Colonic mucosal injury and colitis induced by dextran sodium sulfate (DSS) are ameliorated in epimorphin–/– mice, probably due to the increased proliferative capacity of the epimorphin–/– colon. These in vivo findings support the notion that epimorphin is a key stromal regulator of epithelial cell proliferation and growth in the intestine. In addition, our studies demonstrate a novel and critical role for epimorphin in regulating testicular development and growth as well as spermatogenesis.

Authors

Yuan Wang, Lihua Wang, Hristo Iordanov, Elzbieta A. Swietlicki, Qun Zheng, Shujun Jiang, Yuzhu Tang, Marc S. Levin, Deborah C. Rubin

×

Figure 1

Generation and characterization of epimorphin–/– mice.

Options: View larger image (or click on image) Download as PowerPoint

                  Generation and characterization of epimorphin–/–
    ...
(A) Targeting scheme to disrupt the epimorphin locus. Homologous recombination between the targeting vector and the WT allele produced the targeted allele in which 30 bp of the coding sequence in exon 1 and 1015 bp in intron 1 of the epimorphin gene were replaced by the coding sequence of enhanced GFP and a Neo cassette. The black bar represents the location of the probe used to identify targeted ES cell clones. The arrows denote the position of the initiator methionine of epimorphin and GFP. (B) Southern blot hybridization of Hind III–digested genomic DNA. A 10.4-kb band in the targeted allele and 8.7-kb band in the WT allele were produced as expected. (C) Immunoblot analysis of protein extracts from epimorphin WT (+/+), heterozygous (+/–), and null (–/–) mice. Total protein from small intestine, colon, liver, kidney, and testis (100 μg per tissue) was loaded onto the gel. Epimorphin was reduced in the tissues of heterozygous mice and absent in null mice.

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts